A US health officials meeting is set to take place next month to reconsider a list of peptide drugs. The meeting will include input from doctors and pharmacists who have financial connections to the industry. These peptide drugs are considered unproven chemicals.

The Food and Drug Administration is involved in the meeting, which is scheduled to occur next month. Further details about the meeting and the peptide drugs are available from KSTP 5 Eyewitness News and other sources, including the Associated Press.